# Activity Program During Aromatase Inhibitor Therapy

> **NCT03786198** · NA · COMPLETED · sponsor: **Swiss Cancer Institute** · enrollment: 375 (actual)

## Conditions studied

- Early Breast Cancer

## Interventions

- **BEHAVIORAL:** Activity program
- **BEHAVIORAL:** Control

## Key facts

- **NCT ID:** NCT03786198
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-28
- **Primary completion:** 2021-09-27
- **Final completion:** 2023-06-08
- **Target enrollment:** 375 (ACTUAL)
- **Last updated:** 2023-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03786198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03786198, "Activity Program During Aromatase Inhibitor Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03786198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*